Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman(Inserm), Henry N. Ginsberg(Columbia University), Jan Albert Kuivenhoven(University of Amsterdam), Philippe Lesnik(Sorbonne Université), Pierre Amarenco(Hôpital Bichat-Claude-Bernard), Lâle Tokgözoğlu(Hacettepe University), Željko Reiner, Jan Borén(Sahlgrenska University Hospital), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(University of Helsinki), Gerald F. Watts(The University of Western Australia), Børge G. Nordestgaard(Herlev Hospital), Petri T. Kovanen(Wihuri Research Institute), Edward A. Fisher(New York University), Alberico L. Catapano(University of Milan), Felicita Andreotti, Olivier Descamps(Hôpital de Jolimont), Kausik K. Ray(Imperial College London), Anne Tybjærg‐Hansen(University of Copenhagen)
Cited by 1,226
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k